New reasons not to be depressed about depression
Summary
President Trump's administration allocated $50 million in federal funds to speed up research on psychedelic treatments, such as psilocybin. The goal is to find new ways to help U.S. adults who have depression that does not respond to usual treatments.Key Facts
- The funding amount is $50 million from the federal government.
- The money is aimed at researching psychedelic drugs for depression.
- Psilocybin, a substance found in certain mushrooms, is one of the treatments being studied.
- The focus is on treatment-resistant depression, meaning forms of depression that do not improve with standard medicines.
- This effort is part of President Trump's administration’s health initiatives.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
